Going forward..., page-2075

I actually agree with you that cash will be tight. Our new CBO needs to earn his salary (an undoubtedly options package also) with a partnering agreement that provides upfront cash (and not just another funded trial, as nice as those are). DFU is the most likely but we'll see.

As for running the trial remotely, you do know they're using a CRO don't you? https://en.wikipedia.org/wiki/Contract_research_organization

Many CROs specifically provide clinical-study and clinical-trial support for drugs and/or medical devices.[3][4] However, the sponsor of the trial retains responsibility for the quality of the CRO's work.[5] CROs range from large, international full-service organizations to small, niche specialty groups. CROs that specialize in clinical-trials services can offer their clients the expertise of moving a new drug or device from its conception to FDA/EMA marketing approval,[6] without the drug sponsor having to maintain a staff for these services.[7]

CYP is using IQVIA for this trial

https://www.iqvia.com/solutions/research-and-development#Services